Liabilities / Assets
85th percentile
Higher debt load relative to assets than 85% of similar nonprofits.
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
85th percentile
Higher debt load relative to assets than 85% of similar nonprofits.
Liabilities / Revenue
94th percentile
Higher debt load relative to revenue than 94% of similar nonprofits.
Net Margin
67th percentile
Higher net margin than 67% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
42nd percentile
Faster asset growth than 42% of similar nonprofits.
Revenue Growth
Score unavailable
No earlier valid filing was available within the previous three public years.
Assets
Down$16,131,836
Down $278,368 (-1.7%) from 2010
Net Assets
Up-$1,522,511
Up $269,724 (+15%) from 2010
Liabilities
Down$17,654,347
Down $548,092 (-3.0%) from 2010
Revenue
$3,284,554
No earlier filing loaded for comparison.
Expenses
Up$3,014,830
Up $718,504 (+31%) from 2010
Net Income
$269,724
No earlier filing loaded for comparison.
This 2011 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Biocon, inc. (bio) was formed to serve as the sole voting member of, and act as the holding company for, the musculoskeletal transplant foundation inc., (mtf) a non-profit 501(c) organization and deutsches institut fur zell-und gewebeersatz gmbh, (dizg) a german non-profit organization. Mtf's mission is to provide quality allograft tissues for transplantation, research and education. Dizg specializes in culturing and distribution of keratinocytes, musculoskeletal, and other tissue forms. Bio, as holding company, has authority to approve fundamental amendments to organizational documents and to approve certain corporate transactions such as mergers and dissolutions. Bio also has the exclusive right to elect or appoint all members of the board of directors of mtf and dizg. Bio continues to monitor and guide the activities of mtf and dizg, as well as any affiliates that may be formed or acquired in the future, to foster the provision of high quality human allograft tissue to the community
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2011 • Form 990Summary only. Only limited summary data is available for this year.
Similar nonprofits based on the same Siviq industry and scale cohort. 2011 filings • 501(c)3 • $10M-$25M nonprofits
Irvine, KY
View Organization501(c)3
Revenue vs current organization
No dataAssets vs current organization
About the sameHouston, TX
View Organization501(c)3
Revenue vs current organization
No dataAssets vs current organization
About the sameWinter Haven, FL
View Organization501(c)3
Revenue vs current organization
265% higherAssets vs current organization
About the sameLocation unavailable
View Organization501(c)3
Revenue vs current organization
197% higherAssets vs current organization
About the same